LAMICTAL      ARIPIPRAZOLE      CARBAMAZEPINE      LITHIUM      OLANZAPINE      QUETIAPINE   
   RISPERIDONE      SSRI      TOPIRAMATE      VALPROATE      ZIPRASIDONE   
LAMICTAL        ITALY 
Marketing information
Key claims
Country information
United Kingdom
Germany
Spain
Italy
France
References
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Italy

Indication: For the prevention of depressive episodes in patients with bipolar disorder characterized by the prevalence of depression.
Brand name: Lamictal.
Regulatory status: Pending.
Launch date: Estimated March 2004.

  		  
home help sitemap acronyms help sitemap home